Search for: "Watson Laboratories Inc."
Results 61 - 80
of 177
Sorted by Relevance
|
Sort by Date
1 Apr 2016, 5:30 am
The FTC’s complaint alleges that Endo paid the first generic companies that filed for FDA approval – Impax Laboratories, Inc. and Watson Laboratories, Inc. [read post]
28 Mar 2007, 7:00 pm
In its two dozenth precedential decision of 2007, the Trademark Trial and Appeal Board affirmed a Section 2(e)(4) refusal to register the mark WATSON for "computer software for use in laboratory information management ... [read post]
26 Aug 2012, 9:00 pm
Watson Laboratories, Inc. 3:12-cv-05228; filed August 20, 2012 in the District Court of New Jersey Infringement of U.S. [read post]
9 Mar 2014, 9:31 pm
• Defendants: Actavis plc; Actavis, Inc.; Watson Laboratories, Inc.; Actavis Pharma, Inc. [read post]
Court Of Appeals For Federal Circuit Denies Eli Lilly’s Appeal, Opens Door for Testosterone Generics
5 Dec 2017, 12:29 pm
., Actavis Laboratories UT, Inc., FKA Watson Laboratories Inc., Lupin Pharmaceuticals, Inc., and Lupin LTD infringed patent no. 8,435,944, Method and Composition for Transdermal Drug Delivery (the ‘944 patent) and 8,807,861, Spreading Implement, (the ‘861 patent), which have been issued by the US Patent Office. [read post]
17 Nov 2017, 1:41 pm
Watson Laboratories, Inc., Civil Action No. 16-129-LPS-SRF (D.Del. [read post]
24 Nov 2016, 8:23 pm
Watson Laboratories, Inc. 16-493 Issue: Whether the “on sale” bar found in Section 102(b) of the Patent Act applies only to sales or offers of sale made available to the public, as Congress, this court, and the United States have all made clear, or whether it also applies to non-public sales or offers of sale, as the U.S. [read post]
2 Dec 2009, 11:05 am
On December 2, 2009, the FTC announced an order settling charges that Watson Pharmaceuticals, Inc. [read post]
6 Feb 2013, 4:43 pm
Watson Pharmaceuticals Inc. and Impax Laboratories Inc. both sent letters to Purdue in December, informing the company of their plans to make a generic form of the drug. [read post]
10 Mar 2013, 9:59 pm
Searle LLC; Pfizer Asia Pacific PTE, LTD.; • Defendants: Lupin Pharmaceuticals, Inc.; Teva Pharmaceuticals USA, Inc.; Mylan Pharmaceuticals Inc.; Watson Laboratories, Inc.; Apotex Inc.; Apotex Corp. [read post]
4 Oct 2015, 9:08 pm
Watson Laboratories, Inc. 3:15-cv-05723; filed July 22, 2015 in the District Court of New Jersey Infringement of U.S. [read post]
27 Dec 2012, 6:56 am
Indus., Inc. v. [read post]
24 Dec 2008, 9:04 am
Earlier, Schering and Sepracor have similar settlement agreements with generic manufacturers including Ranbaxy, Perrigo Co. and Watson Pharmaceuticals Inc. [read post]
25 Feb 2011, 7:12 am
(collectively "Shire") have received a new Paragraph IV Notice Letter from Watson Laboratories, Inc. in Fort Lauderdale, Florida ("Watson") advising of the filing of an Abbreviated New Drug Application ("ANDA") for a generic version of all approved strengths of Shire's ADDERALL XR(R) (mixed salts of a single-entity amphetamine product) dextroamphetamine sulphate, dextroamphetamine saccharate, amphetamine aspartate monohydrate,… [read post]
16 Jun 2014, 8:04 am
Watson Laboratories, Inc. [read post]
24 Jun 2017, 1:16 pm
Stark in UCB, Inc., et al. v. [read post]
19 Feb 2014, 6:57 am
• Watson Laboratories, Inc. [read post]
FTC and California AG Join in Challenging Reverse Payment Settlements in the Pharmaceutical Industry
6 Mar 2009, 7:03 am
Watson Pharm., Inc. et al., 09-cv-00598 (AHM) ("Watson"). [read post]
8 Dec 2010, 6:07 pm
Other GnRH drugs include Watson Pharmaceuticals Inc's Trelstar and Endo Pharmaceuticals Holdings Inc's Vantas. [read post]
9 Oct 2009, 9:11 am
Watson Pharmaceuticals Inc., Watson Laboratories, Inc. and Watson Pharma Inc. [read post]
